Home

Oxygenta Pharmaceutical Ltd Board of Directors

Board of Directors at Oxygenta Pharmaceutical Ltd

Aakanksha

Additional Director

Bharath Guntuku

Additional Director

D Sagar

Independent Director

Dolly Mandhan

Company Sec. & Compli. Officer

Kanuganti Rao

Executive Director

Key Highlights

  • Sai Sudhakar Vankineni continues to serve as the Chairman & Managing Director in 2024, maintaining the same position as in the previous year.
  • Sangari Kondal Reddy continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
  • Padmaja Surapureddy continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
  • Kanuganti Raghavender Rao joins the board as Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Sravani Reddy Gantla joins the board as Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

Share Price

-

-

stock direction

Last updated on:

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Mar 202577.43
12 Mar 202579.01
11 Mar 202579.4
10 Mar 202577.87
07 Mar 202576.35
06 Mar 202574.86
05 Mar 202573.4
04 Mar 202571.97
03 Mar 202573.43
28 Feb 202574.92

Company Fundamentals for Oxygenta Pharmaceutical Ltd

Market Cap

286 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

0.0

Day’s High

78.62

Day’s Low

77.43

DTE

-2.9

ROE

-0.1

52 Week High

108.64

52 Week Low

27.62

ROCE

-24.5

Market Price of Oxygenta Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Oxygenta Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Oxygenta Pharmaceutical Ltd News Hub

Oxygenta Pharmaceutical reports standalone net loss of Rs 1.36 crore in the June 2024 quarter

Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 2024 as agai

Read more

16 Aug 24

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 August 20

Read more

12 Aug 24

Oxygenta Pharmaceutical schedules AGM

Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the company will be

Read more

18 Sept 24

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 November

Read more

11 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Board of Directors of Oxygenta Pharmaceutical Ltd

How are members of Oxygenta Pharmaceutical Ltd Board of Directors selected?

Members of the Oxygenta Pharmaceutical Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Oxygenta Pharmaceutical Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Oxygenta Pharmaceutical Ltd Board of Directors?

Shareholders can interact with the Oxygenta Pharmaceutical Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Oxygenta Pharmaceutical Ltd Board of Directors meet?

The Oxygenta Pharmaceutical Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Oxygenta Pharmaceutical Ltd Board of Directors?

The Oxygenta Pharmaceutical Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Oxygenta Pharmaceutical Ltd?

The current Board of Directors at Oxygenta Pharmaceutical Ltd includes Sai Sudhakar Vankineni( Chairman & Managing Director) ,Sangari Kondal Reddy( Independent Director) ,Padmaja Surapureddy( Independent Director) ,Kanuganti Raghavender Rao( Executive Director) ,Sravani Reddy Gantla( Executive Director) . The full list can be found on Oxygenta Pharmaceutical Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions